TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial.

Chloe Orkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.